Header Logo

Oren Schaefer

Concepts (63)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonia
2
2005
289
0.210
Why?
Suppuration
1
2003
11
0.210
Why?
Mycobacterium avium Complex
1
2003
3
0.210
Why?
Mycobacterium avium-intracellulare Infection
1
2003
8
0.210
Why?
Respiratory Tract Infections
1
2003
89
0.190
Why?
Bacterial Infections
1
2003
148
0.180
Why?
Cough
1
2003
183
0.180
Why?
Complement C1 Inhibitor Protein
1
2010
1
0.090
Why?
Angioedemas, Hereditary
1
2010
1
0.090
Why?
Complement Inactivating Agents
1
2010
14
0.090
Why?
Severity of Illness Index
2
2005
1543
0.080
Why?
Mianserin
1
2005
3
0.060
Why?
Oxazolidinones
1
2005
13
0.060
Why?
Serotonin Syndrome
1
2005
10
0.060
Why?
Acetamides
1
2005
13
0.060
Why?
Citalopram
1
2005
21
0.060
Why?
Urticaria
1
2004
7
0.050
Why?
Antidepressive Agents
1
2005
225
0.050
Why?
Triage
1
2005
128
0.050
Why?
Hypothermia, Induced
1
2004
40
0.050
Why?
Cold Temperature
1
2004
51
0.050
Why?
Patient Admission
1
2005
193
0.050
Why?
Immunocompetence
1
2003
21
0.050
Why?
Bronchoscopy
1
2003
87
0.050
Why?
Intensive Care Units
1
2005
406
0.050
Why?
Aortic Valve
1
2004
190
0.050
Why?
Coronary Artery Bypass
1
2004
297
0.050
Why?
Heart Valve Prosthesis Implantation
1
2004
172
0.050
Why?
Radiography
1
2003
540
0.040
Why?
Diagnosis, Differential
1
2003
968
0.040
Why?
Chronic Disease
1
2003
753
0.040
Why?
Middle Aged
4
2005
17468
0.040
Why?
Anti-Bacterial Agents
1
2005
787
0.040
Why?
Female
5
2010
32707
0.030
Why?
Adult
3
2010
16731
0.030
Why?
Aged
3
2005
14327
0.030
Why?
Humans
6
2010
63155
0.030
Why?
Adolescent
1
2003
6226
0.020
Why?
Male
4
2010
29713
0.020
Why?
Retrospective Studies
1
2003
6594
0.020
Why?
Ultrafiltration
1
2010
13
0.020
Why?
Cross-Over Studies
1
2010
161
0.020
Why?
Infusions, Intravenous
1
2010
174
0.020
Why?
Nanotechnology
1
2010
135
0.020
Why?
Analysis of Variance
1
2010
608
0.020
Why?
Acute Disease
1
2010
671
0.020
Why?
Double-Blind Method
1
2010
737
0.020
Why?
Proportional Hazards Models
1
2010
729
0.020
Why?
Linezolid
1
2005
6
0.020
Why?
Protein Synthesis Inhibitors
1
2005
23
0.020
Why?
Drug Synergism
1
2005
143
0.020
Why?
Bone Marrow Transplantation
1
2005
139
0.010
Why?
Transplantation, Homologous
1
2005
243
0.010
Why?
Urinary Tract Infections
1
2005
91
0.010
Why?
Community-Acquired Infections
1
2005
94
0.010
Why?
Rewarming
1
2004
6
0.010
Why?
Leukemia, Myeloid, Acute
1
2005
192
0.010
Why?
Sensitivity and Specificity
1
2005
1142
0.010
Why?
Pilot Projects
1
2005
1004
0.010
Why?
Child
1
2010
4518
0.010
Why?
Risk Assessment
1
2005
2066
0.010
Why?
Aged, 80 and over
1
2005
5430
0.010
Why?
United States
1
2005
7805
0.010
Why?
Schaefer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_